Top Page
Mindax Limited
(Sydney:MDX)
Mindax Limited (MDX) vs. iShares MSCI Australia ETF (EWA)
Mindax Limited Business Overview & Revenue Model
Mindax Limited Financial Statement Overview
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 2.99K | 0.00 | 59.96K | 0.00 |
| Gross Profit | -56.48K | -67.70K | 2.99K | -11.46K | 59.96K | -1.11K |
| EBITDA | -2.98M | -2.55M | -2.54M | -1.91M | -1.08M | -1.91M |
| Net Income | -2.85M | -2.85M | -2.28M | -5.57M | 13.42M | -1.13M |
Balance Sheet | ||||||
| Total Assets | 30.14M | 33.93M | 26.73M | 19.32M | 18.98M | 4.25M |
| Cash, Cash Equivalents and Short-Term Investments | 146.18K | 1.32M | 520.04K | 4.63M | 1.68M | 1.19M |
| Total Debt | 30.20K | 58.69K | 108.65K | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.90M | 8.67M | 2.13M | 273.95K | 360.74K | 396.83K |
| Stockholders Equity | 21.64M | 18.61M | 17.68M | 19.05M | 18.62M | 3.85M |
Cash Flow | ||||||
| Free Cash Flow | -2.33M | -1.85M | -4.38M | -2.40M | -965.54K | -2.00M |
| Operating Cash Flow | -2.33M | -1.85M | -1.83M | -1.44M | -965.54K | -1.36M |
| Investing Cash Flow | -7.69M | -5.00M | -2.33M | -1.00M | 208.51K | -644.86K |
| Financing Cash Flow | 9.56M | 7.65M | 57.73K | 5.39M | 1.25M | 3.01M |
Mindax Limited Technical Analysis
Mindax Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | AU$130.81M | 3.56 | 14.07% | 4.01% | 24.48% | 97.18% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | AU$336.28M | 5.17 | -20.84% | ― | 11.43% | -238.93% | |
49 Neutral | AU$237.14M | -4.78 | -8.87% | ― | ― | 15.86% | |
47 Neutral | AU$73.26M | -23.30 | -14.18% | ― | ― | -18.18% | |
46 Neutral | AU$147.06M | 26.76 | -1.46% | ― | ― | 71.98% | |
43 Neutral | AU$229.42M | 3.94 | -3.40% | ― | ― | ― |
Mindax Limited Corporate Events
Mindax Limited has released its interim financial report for the half-year ended 31 December 2025, providing condensed financial statements and disclosures that are intended to be read alongside its 30 June 2025 annual report. The document includes the directors’ report, auditor’s independence declaration, consolidated financial statements, notes, and an independent auditor’s review, fulfilling the company’s interim reporting and continuous disclosure obligations under the Corporations Act 2001.
The release does not add detailed operational or strategic updates but primarily serves as a regulatory and transparency measure for stakeholders tracking Mindax’s financial position and performance between full-year reporting periods. Investors and regulators are directed to combine this interim report with prior annual disclosures and other public announcements to gain a complete view of the company’s current financial status and compliance posture.
The most recent analyst rating on (AU:MDX) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on Mindax Limited stock, see the AU:MDX Stock Forecast page.
Mindax Limited has issued 4,333,333 fully paid ordinary shares on 11 March 2026, expanding its capital base and notifying the market that these securities were issued without a disclosure document. The company has confirmed that the new shares qualify for secondary trading under section 708A(5) of the Corporations Act, enabling on-sale without further disclosure.
In its notice, Mindax stated it is up to date with its financial reporting and continuous disclosure obligations, and that there is no withheld information material to assessing its financial position or the rights attached to the new securities. This assurance supports market transparency and gives investors confidence that trading in the newly issued shares can occur on an informed basis within the ASX framework.
The most recent analyst rating on (AU:MDX) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on Mindax Limited stock, see the AU:MDX Stock Forecast page.
Mindax Limited has applied for quotation of 4,333,333 new ordinary fully paid shares on the Australian Securities Exchange, with an issue date of 11 March 2026. The securities form part of transactions previously flagged to the market, signalling the formal progression of its capital issuance and potentially increasing liquidity and free float for existing and new shareholders.
The application under Appendix 2A confirms compliance with ASX requirements for listing additional securities. While the announcement is procedural in nature, the expanded quoted capital base may support Mindax’s financing flexibility and could modestly influence ownership dispersion and trading dynamics in its stock.
The most recent analyst rating on (AU:MDX) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on Mindax Limited stock, see the AU:MDX Stock Forecast page.
Mindax Limited has notified the ASX of a proposed placement of up to 4,333,333 ordinary fully paid shares. The new securities, to be issued on 11 March 2026, reflect the company’s ongoing use of equity markets to access capital, which may affect its capital structure and share base once the issue is completed.
The placement signals continued engagement with investors and could provide additional funding flexibility for Mindax’s operations or strategic initiatives. Existing shareholders may see dilution depending on the company’s current shares on issue, while the move underscores the firm’s reliance on public market financing to support its future plans.
The most recent analyst rating on (AU:MDX) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on Mindax Limited stock, see the AU:MDX Stock Forecast page.
Mindax Limited has issued 2,702,703 fully paid ordinary shares on 11 February 2026, expanding its share capital base. The new securities were issued without a disclosure document, in accordance with provisions of the Corporations Act that allow such placements under certain conditions.
The company confirmed it is in compliance with its financial reporting and continuous disclosure obligations and stated there is no withheld price-sensitive information relevant to assessing the new shares. As a result of this notice, the new shares qualify for secondary trading exemption, enabling investors to freely on-sell them without further disclosure requirements, which may support liquidity in the stock.
The most recent analyst rating on (AU:MDX) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Mindax Limited stock, see the AU:MDX Stock Forecast page.
Mindax Limited has applied to the ASX for quotation of 2,702,703 ordinary fully paid shares, formalising the listing of these additional securities under its existing MDX code. The new shares were issued on 11 February 2026 as part of transactions previously flagged to the market, modestly increasing the company’s quoted capital base and potentially enhancing liquidity for shareholders.
The application confirms compliance with ASX Listing Rule requirements for quotation of the new securities, indicating the shares rank equally with existing ordinary stock. While the announcement does not outline the underlying purpose of the prior transactions, the incremental expansion of Mindax’s issued capital may support ongoing corporate or project funding needs and slightly broaden its investor participation on the exchange.
The most recent analyst rating on (AU:MDX) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Mindax Limited stock, see the AU:MDX Stock Forecast page.
Mindax Limited has notified the ASX of a proposed issue of up to 2,702,703 ordinary fully paid shares under a placement or similar capital-raising structure. The new securities, to be issued on 10 February 2026, represent an additional equity raising that will expand the company’s share base and may provide further funding capacity for its ongoing activities and strategic initiatives.
The placement underscores Mindax’s continuing reliance on the equity markets to support its growth and operational plans while maintaining its ASX quotation status. Existing shareholders may experience dilution from the expanded register, but the capital injection could strengthen the company’s financial position and flexibility in pursuing future projects or investments.
The most recent analyst rating on (AU:MDX) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Mindax Limited stock, see the AU:MDX Stock Forecast page.
Mindax Limited has notified the market of the issue of 58 million unquoted options, exercisable at $0.08 and expiring on 30 November 2026, under its ASX code MDXAT. The new options, which were previously flagged to the market, will not be quoted on the ASX and represent a significant increase in the company’s unquoted equity securities, potentially affecting capital structure and future dilution for existing shareholders.
The most recent analyst rating on (AU:MDX) stock is a Sell with a A$0.04 price target. To see the full list of analyst forecasts on Mindax Limited stock, see the AU:MDX Stock Forecast page.
Mindax Limited’s December 2025 quarter was marked by continued advancement of its Mt Forrest Iron Project and associated Mid-West infrastructure plans, alongside ongoing capital raisings. The company issued 58 million options to directors and related parties following shareholder approval, dispatched four tonnes of high‑grade magnetite samples from Mt Forrest for metallurgical testing to underpin future development studies, and continued discussions to secure development partners while progressing toward acquiring full ownership of the project. In parallel, Mindax maintained engagement with potential stakeholders to progress the Mid-West Shared Infrastructure Project, building on a completed phase two viability study, and raised working capital through share placements under an existing mandate to sustain project momentum, including its nearby Mt Lucky Gold Project.
The most recent analyst rating on (AU:MDX) stock is a Sell with a A$0.04 price target. To see the full list of analyst forecasts on Mindax Limited stock, see the AU:MDX Stock Forecast page.